| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $191M | — | $220M | — | -13.1% |
| Op. Income | $39M | — | $24M | — | 60.0% |
| Gross Margin | 100.0% | — | 85.3% | — | 14.7pp |
| Net Margin | 18.4% | — | 8.7% | — | 9.7pp |
| EPS (Diluted) | $2.61 | — | $1.39 | — | 87.8% |
| Free Cash Flow | $32M | — | $30M | — | 7.3% |
| Item | Amount |
|---|---|
| REVENUE | $191M |
| Cost of Revenue | $0 |
| GROSS PROFIT | $191M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $152M |
| Operating Expenses | $152M |
| Cost & Expenses | $152M |
| OPERATING INCOME | $39M |
| Interest Income | $81M |
| Interest Expense | $0 |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $39M |
| Income Tax Expense | $8M |
| Net Income from Continuing Ops | $31M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $4M |
| NET INCOME | $35M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $35M |
| D&A | $0 |
| EBIT | $39M |
| EBITDA | $39M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| REVENUE | $191M |
| Cost of Revenue | $0 |
| GROSS PROFIT | $191M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $152M |
| Operating Expenses | $152M |
| Cost & Expenses | $152M |
| OPERATING INCOME | $39M |
| Interest Income | $81M |
| Interest Expense | $0 |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $39M |
| Income Tax Expense | $8M |
| Net Income from Continuing Ops | $31M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $4M |
| NET INCOME | $35M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $35M |
| D&A | $0 |
| EBIT | $39M |
| EBITDA | $39M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| Net Income | $35M |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $4M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $5M |
| Change in Working Capital | -$7M |
| OPERATING CASH FLOW | $37M |
| Capital Expenditure | -$6M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$145M |
| NET CASH FROM INVESTING | -$145M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$26M |
| Common Dividends Paid | -$17M |
| Other Financing Activities | $193M |
| NET CASH FROM FINANCING | $150M |
| FREE CASH FLOW | $32M |
| Net Change in Cash | $43M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $392M |
| Short-Term Investments | $0 |
| Net Receivables | $1.1B |
| Inventory | $0 |
| Other Current Assets | -$277M |
| TOTAL CURRENT ASSETS | $1.2B |
| PP&E (Net) | $29M |
| Goodwill | $16M |
| Intangible Assets | $20M |
| Long-Term Investments | $771M |
| Tax Assets | $0 |
| Other Non-Current Assets | -$771M |
| TOTAL NON-CURRENT ASSETS | $49M |
| TOTAL ASSETS | $2.6B |
| Account Payables | $1.1B |
| Short-Term Debt | $826.0K |
| Deferred Revenue | $0 |
| Other Current Liabilities | -$826.0K |
| TOTAL CURRENT LIABILITIES | $1.1B |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $1.2B |
| TOTAL NON-CURRENT LIABILITIES | $1.2B |
| TOTAL LIABILITIES | $2.4B |
| Common Stock | $8M |
| Additional Paid-In Capital | $207M |
| Retained Earnings | $167M |
| Treasury Stock | -$112M |
| Accum. Other Comp. Income | -$27M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $243M |
| Minority Interest | $0 |
| TOTAL EQUITY | $243M |
| TOTAL LIABILITIES & EQUITY | $2.6B |
| Total Debt | $5M |
| Net Debt | -$388M |
